A A A
-->

Publikationen

Publikationen der Jahre:   2013   2014   2015   2016   2017

                                        

 

2017

 

Amara AW, Chahine LM, Caspell-Garcia C, Long JD, Coffey C, Högl B, Videnovic A, Iranzo A, Mayer G, Foldvary-Schaefer N, Postuma R, Oertel W, Lasch S, Marek K, Simuni T.  Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease. J Neurol Neurosurg Psychiatry. 88(8):653-662

Barbe AG, Heinzler A, Derman S, Hellmich M, Timmermann L, Noack MJ.  Hyposalivation and xerostomia among Parkinson's disease patients and its impact on quality of life. Oral Dis. 23(4):464-470

Becker J, Barbe MT, Hartinger M, Dembek TA, Pochmann J, Wirths J, Allert N, Mücke D, Hermes A, Meister IG, Visser-Vandewalle V, Grice M, Timmermann L.  The Effect of Uni- and Bilateral Thalamic Deep Brain Stimulation on Speech in Patients With Essential Tremor: Acoustics and Intelligibility. Neuromodulation. 20(3):223-232

Blumcke I, Spreafico R, Haaker G, Coras R, Kobow K, Bien CG, Pfäfflin M, Elger C, Widman G, Schramm J, Becker A, Braun KP, Leijten F, Baayen JC, Aronica E, Chassoux F, Hamer H, Stefan H, Rössler K, Thom M, Walker MC, Sisodiya SM, Duncan JS, McEvoy AW, Pieper T, Holthausen H, Kudernatsch M, Meencke HJ, Kahane P, Schulze-Bonhage A, Zentner J, Heiland DH, Urbach H, Steinhoff BJ, Bast T, Tassi L, Lo Russo G, Özkara C, Oz B, Krsek P, Vogelgesang S, Runge U, Lerche H, Weber Y, Honavar M, Pimentel J, Arzimanoglou A, Ulate-Campos A, Noachtar S, Hartl E, Schijns O, Guerrini R, Barba C, Jacques TS, Cross JH, Feucht M, Mühlebner A, Grunwald T, Trinka E, Winkler PA, Gil-Nagel A, Toledano Delgado R, Mayer T, Lutz M, Zountsas B, Garganis K, Rosenow F, Hermsen A, von Oertzen TJ, Diepgen TL, Avanzini G. Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery. N Engl J Med. 377(17):1648-1656

Bougea A, Koros C, Stamelou M, Simitsi A, Papagiannakis N, Antonelou R, Papadimitriou D, Breza M, Tasios K, Fragkiadaki S, Geronicola Trapali X, Bourbouli M, Koutsis G, Papageorgiou SG, Kapaki E, Paraskevas GP, Stefanis L.  Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein gene. Parkinsonism Relat Disord. 35:82-87

Buecking B, Eschbach D, Knobe M, Oberkircher L, Balzer-Geldsetzer M, Dodel R, Sielski R, Doering B, Ruchholtz S, Bliemel C.  Predictors of noninstitutionalized survival 1 year after hip fracture: A prospective observational study to develop the Marburg Rehabilitation Tool for Hip fractures (MaRTHi). Medicine (Baltimore) 96(37):e7820.

Conrad C, Dorzweiler K, Miller MA, Lauffenburger DA, Strik H, Bartsch JW.  Profiling of metalloprotease activities in cerebrospinal fluids of patients with neoplastic meningitis. Fluids Barriers CNS. 14(1):22

de Roos P, Bloem BR, Kelley TA, Antonini A, Dodel R, Hagell P, Marras C, Martinez-Martin P, Mehta SH, Odin P, Chaudhuri KR, Weintraub D, Wilson B, Uitti RJ.  A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement.  J Parkinsons Dis. 7(3):533-543

Dembek TA, Reker P, Visser-Vandewalle V, Wirths J, Treuer H, Klehr M, Roediger J, Dafsari HS, Barbe MT, Timmermann L.  Directional DBS increases side-effect thresholds-A prospective, double-blind trial. Mov Disord. (10):1380-1388

Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, Höffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, Oertel WH.  Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease. Acta Neuropathol. 133(4):535-545

Enders D, Balzer-Geldsetzer M, Riedel O, Dodel R, Wittchen HU, Sensken SC, Wolff B, Reese JP.  Prevalence, Duration and Severity of Parkinson's Disease in Germany: A Combined Meta-Analysis from Literature Data and Outpatient Samples. Eur Neurol. 78(3-4):128-136

Fernández O, Delvecchio M, Edan G, Fredrikson S, Gionvannoni G, Hartung HP, Havrdova E, Kappos L, Pozzilli C, Soerensen PS, Tackenberg B, Vermersch P, Comi G.  Survey of diagnostic and treatment practices for multiple sclerosis in Europe. Eur J Neurol. 24(3):516-522

Fischer S, Lamping M, Gold M, Röttger Y, Brödje D, Dodel R, Frantz R, Mraheil MA, Chakraborty T, Geyer A.  Synthesis of a biological active β-hairpin peptide by addition of two structural motifs. Bioorg Med Chem. 25(2):603-608

Hamel W, Köppen JA, Alesch F, Antonini A, Barcia JA, Bergman H, Chabardes S, Contarino MF, Cornu P, Demmel W, Deuschl G, Fasano A, Kühn AA, Limousin P, McIntyre CC, Mehdorn HM, Pilleri M, Pollak P, Rodríguez-Oroz MC, Rumià J, Samuel M, Timmermann L, Valldeoriola F, Vesper J, Visser-Vandewalle V, Volkmann J, Lozano AM.  Targeting of the Subthalamic Nucleus for Deep Brain Stimulation: A Survey Among Parkinson Disease Specialists. World Neurosurg. 99:41-46

Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord. 32(6):853-864

Höglinger GU, Schöpe J, Stamelou M, Kassubek J, Del Ser T, Boxer AL, Wagenpfeil S, Huppertz HJ.  Longitudinal magnetic resonance imaging in progressive supranuclear palsy: A new combined score for clinical trials. Mov Disord. 32(6):842-852

Höllerhage M, Moebius C, Melms J, Chiu WH, Goebel JN, Chakroun T, Koeglsperger T, Oertel WH, Rösler TW, Bickle M, Höglinger GU. Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells. Sci Rep. 7(1):11469

Jones RW, Lebrec J, Kahle-Wrobleski K, Dell'Agnello G, Bruno G, Vellas B, Argimon JM, Dodel R, Haro JM, Wimo A, Reed C.  Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes. Dement Geriatr Cogn Dis Extra 7(1):87-100

Kienzler-Norwood F, Costard L, Sadangi C, Müller P, Neubert V, Bauer S, Rosenow F, Norwood BA.  A novel animal model of acquired human temporal lobe epilepsy based on the simultaneous administration of kainic acid and lorazepam.  Epilepsia. 58(2):222-230

Knake S, Roth C, Belke M, Sonntag J, Kniess T, Krach S, Jansen A, Sommer J, Paulus FM, Carl B, Rosenow F, Hermsen AM, Menzler K.  Microstructural white matter changes and their relation to neuropsychological deficits in patients with juvenile myoclonic epilepsy. Epilepsy Behav. 76:56-62

Kordys E, Apetz N, Schneider K, Duncan E, Büschbell B, Rohleder C, Sué M, Drzezga A, Neumaier B, Timmermann L, Endepols H.  Motor impairment and compensation in a hemiparkinsonian rat model: correlation between dopamine depletion severity, cerebral metabolism and gait patterns. EJNMMI Res. 7(1):68

Kortland LM, Knake S, von Podewils F, Rosenow F, Strzelczyk A.  Socioeconomic Outcome and Quality of Life in Adults after Status Epilepticus: A Multicenter, Longitudinal, Matched Case-Control Analysis from Germany. Front Neurol. 8:507

Lahut S, Gispert S, Ömür Ö, Depboylu C, Seidel K, Domínguez-Bautista JA, Brehm N, Tireli H, Hackmann K, Pirkevi C, Leube B, Ries V, Reim K, Brose N, den Dunnen WF, Johnson M, Wolf Z, Schindewolf M, Schrempf W, Reetz K, Young P, Vadasz D, Frangakis AS, Schröck E, Steinmetz H, Jendrach M, Rüb U, Başak AN, Oertel W, Auburger G.  Blood RNA biomarkers in prodromal PARK4 and rapid eye movement sleep behavior disorder show role of complexin 1 loss for risk of Parkinson's disease. Dis Model Mech. 10(5):619-631

Lasser-Katz E, Simchovitz A, Chiu WH, Oertel WH, Sharon R, Soreq H, Roeper J, Goldberg JA.  Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease. J Neurosci. 37(1):47-57

Lueken U, Evens R, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Gräber-Sultan S, Hilker-Roggendorf R, Kalbe E, Kaut O, Mollenhauer B, Reetz K, Schäffer E, Schmidt N, Schulz JB, Spottke A, Witt K, Linse K, Storch A, Riedel O.  Psychometric properties of the apathy evaluation scale in patients with Parkinson's disease. Int J Methods Psychiatr Res. 26(4). doi: 10.1002/mpr.1564

Maier F, Lewis CJ, Eggers C, Kühn AA, Krug H, Volkmann J, Kirsch AD, Wojtecki L, Schnitzler A, Deuschl G, Krauss JK, Woopen C, Timmermann L.  Development and validation of the deep brain stimulation impairment scale (DBS-IS). Parkinsonism Relat Disord. 36:69-75

Marquetand J, Knake S, Strzelczyk A, Steinhoff BJ, Lerche H, Synofzik M, Focke NK.  Periodic EEG patterns in sporadic Creutzfeld-Jakob-Disease can be benzodiazepine-responsive and be difficult to distinguish from non-convulsive status epilepticus.  Periodic EEG patterns in sporadic Creutzfeld-Jakob-Disease can be benzodiazepine-responsive and be difficult to distinguish from non-convulsive status epilepticus. Seizure. 53:47-50

Mayer G, Rodenbeck A, Kesper K; International Xyrem Study Group.  Sodium oxybate treatment in narcolepsy and its effect on muscle tone. Sleep Med. 35:1-6

McArdle H, Jimenez-Mateos EM, Raoof R, Carthy E, Boyle D, ElNaggar H, Delanty N, Hamer H, Dogan M, Huchtemann T, Kӧrtvelyessy P, Rosenow F, Forster RJ, Henshall DC, Spain E.  TORNADO - Theranostic One-Step RNA Detector; microfluidic disc for the direct detection of microRNA-134 in plasma and cerebrospinal fluid. Sci Rep. 7(1):1750

Meles SK, Vadasz D, Renken RJ, Sittig-Wiegand E, Mayer G, Depboylu C, Reetz K, Overeem S, Pijpers A, Reesink FE, van Laar T, Heinen L, Teune LK, Höffken H, Luster M, Kesper K, Adriaanse SM, Booij J, Leenders KL, Oertel WH.  FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder. Mov Disord. 32(10):1482-1486

Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Shaw LM, Trojanowski JQ, Singleton A, Frasier M, Marek K, Galasko D; Parkinson's Progression Marker Initiative (hierin: Oertel WH).  Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls. Neurology. 89(19):1959-1969

Müller-Rebstein S, Trenkwalder C, Ebentheuer J, Oertel WH, Culmsee C, Höglinger GU.  Drug Safety Analysis in a Real-Life Cohort of Parkinson's Disease Patients with Polypharmacy. CNS Drugs. 31(12):1093-1102

Oertel W, Eggert K, Pahwa R, Tanner CM, Hauser RA, Trenkwalder C, Ehret R, Azulay JP, Isaacson S, Felt L, Stempien MJ.  Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3). Mov Disord. 32(12): 1701-1709

Pauls KAM, Krauss JK, Kämpfer CE, Kühn AA, Schrader C, Südmeyer M, Allert N, Benecke R, Blahak C, Boller JK, Fink GR, Fogel W, Liebig T, El Majdoub F, Mahlknecht P, Kessler J, Mueller J, Voges J, Wittstock M, Wolters A, Maarouf M, Moro E, Volkmann J, Bhatia KP, Timmermann L.  Causes of failure of pallidal deep brain stimulation in cases with pre-operative diagnosis of isolated dystonia. Parkinsonism Relat Disord. 43:38-48 

Pedrosa DJ, Nelles C, Brown P, Volz LJ, Pelzer EA, Tittgemeyer M, Brittain JS, Timmermann L.  The differentiated networks related to essential tremor onset and its amplitude modulation after alcohol intake. Exp Neurol. 297:50-61

Pelzer EA, Nelles C, Pedrosa DJ, Eggers C, Burghaus L, Melzer C, Tittgemeyer M, Timmermann L.  Structural differences in impaired verbal fluency in essential tremor patients compared to healthy controls. Brain Behav. 7(7):e00722

Pérez-Palma E, Helbig I, Klein KM, Anttila V, Horn H, Reinthaler EM, Gormley P, Ganna A, Byrnes A, Pernhorst K, Toliat MR, Saarentaus E, Howrigan DP, Hoffman P, Miquel JF, De Ferrari GV, Nürnberg P, Lerche H, Zimprich F, Neubauer BA, Becker AJ, Rosenow F, Perucca E, Zara F, Weber YG, Lal D.  Heterogeneous contribution of microdeletions in the development of common generalised and focal epilepsies. J Med Genet. 54(9):598-606

Rajman M, Metge F, Fiore R, Khudayberdiev S, Aksoy-Aksel A, Bicker S, Ruedell Reschke C, Raoof R, Brennan GP, Delanty N, Farrell MA, O'Brien DF, Bauer S, Norwood B, Veno MT, Krüger M, Braun T, Kjems J, Rosenow F, Henshall DC, Dieterich C, Schratt G.  A microRNA-129-5p/Rbfox crosstalk coordinates homeostatic downscaling of excitatory synapses. EMBO J. 36(12):1770-1787

Rangel RH, Möller L, Sitter H, Stibane T, Strzelczyk A.  Sure, or unsure? Measuring students' confidence and the potential impact on patient safety in multiple-choice questions. Med Teach. 39(11):1189-1194

Raoof R, Jimenez-Mateos EM, Bauer S, Tackenberg B, Rosenow F, Lang J, Onugoren MD, Hamer H, Huchtemann T, Körtvélyessy P, Connolly NMC, Pfeiffer S, Prehn JHM, Farrell MA, O'Brien DF, Henshall DC, Mooney C.  Cerebrospinal fluid microRNAs are potential biomarkers of temporal lobe epilepsy and status epilepticus. Sci Rep. 7(1):3328

Reed C, Barrett A, Lebrec J, Dodel R, Jones RW, Vellas B, Wimo A, Argimon JM, Bruno G, Haro JM.  How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease? Health Qual Life Outcomes. 15(1):16

Reed C, Happich M, Argimon JM, Haro JM, Wimo A, Bruno G, Dodel R, Jones RW, Vellas B, Belger M.  What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study. J Alzheimers Dis. 57(3):797-812

Reschke CR, Silva LF, Norwood BA, Senthilkumar K, Morris G, Sanz-Rodriguez A, Conroy RM, Costard L, Neubert V, Bauer S, Farrell MA, O'Brien DF, Delanty N, Schorge S, Pasterkamp RJ, Rosenow F, Henshall DC.  Potent Anti-seizure Effects of Locked Nucleic Acid Antagomirs Targeting miR-134 in Multiple Mouse and Rat Models of Epilepsy. Mol Ther Nucleic Acids. 6:45-56

Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan, I,Stamelou M, Höglinger GU.  Which ante mortem clinical features predict progressive supranuclear palsy pathology? Mov Disord. 2(7):995-1005

Sadangi C, Rosenow F, Norwood BA.  Validation of reference genes for quantitative gene expression analysis in experimental epilepsy. J Neurosci Res. 95(12):2357-2366

Steinig I, von Podewils F, Möddel G, Bauer S, Klein KM, Paule E, Reif PS, Willems LM, Zöllner JP, Kunz R, Runge U, Kurlemann G, Schubert-Bast S, Rosenow F, Strzelczyk A.  Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany. Epilepsia. 58(7):1208-1216

Strzelczyk A, Ansorge S, Hapfelmeier J, Bonthapally V, Erder MH, Rosenow F.  Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany. Epilepsia. 58(9):1533-1541

Timmermann L, Oehlwein C, Ransmayr G, Fröhlich H, Will E, Schroeder H, Lauterbach T, Bauer L, Kassubek J.  Patients' perception of Parkinson's disease-associated pain following initiation of rotigotine: a multicenter non-interventional study. Postgrad Med. 129(1):46-54

Trenkwalder C, Winkelmann J, Oertel W, Virgin G, Roubert B, Mezzacasa A.  Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial. Mov Disord. 32(10):1478-1482

Voigt-Radloff S, de Werd MM, Leonhart R, Boelen DH, Olde Rikkert MG, Fliessbach K, Klöppel S, Heimbach B, Fellgiebel A, Dodel R, Eschweiler GW, Hausner L, Kessels RP, Hüll M.  Structured relearning of activities of daily living in dementia: the randomized controlled REDALI-DEM trial on errorless learning. Alzheimers Res Ther. 9(1):22

von Papen M, Dafsari H, Florin E, Gerick F, Timmermann L, Saur J.  Phase-coherence classification: A new wavelet-based method to separate local field potentials into local (in)coherent and volume-conducted components. J Neurosci Methods. 291:198-212

Wagner J, Vulinović F, Grünewald A, Unger MM, Möller JC, Klein C, Michel PP, Ries V, Oertel WH, Alvarez-Fischer D.  Acylated and unacylated ghrelin confer neuroprotection to mesencephalic neurons.  Neuroscience. 365:137-145

Weber I, Florin E, von Papen M, Timmermann L.  The influence of filtering and downsampling on the estimation of transfer entropy. PLoS One. 12(11):e0188210

 

2016

 

Alesch F, Jain R, Chen L, Brucke T, Seijo F, San Martin ES, Haegelen C, Verin M, Maarouf M, Barbe MT, Gill S, Whone A, Porta M, Servello D, Timmermann L.  135 A Comparison of Outcomes Between Deep Brain Stimulation Under General Anesthesia Versus Conscious Sedation With Awake Evaluation.  Neurosurgery. 63 Suppl 1:155

"Andlauer TF, Buck D, Antony G, Bayas A, Bechmann L, Berthele A, Chan A, Gasperi C, Gold R, Graetz C, Haas J, Hecker M, Infante-Duarte C, Knop M, Kümpfel T, Limmroth V, Linker RA, Loleit V, Luessi F, Meuth SG, Mühlau M, Nischwitz S, Paul F, Pütz M, Ruck T, Salmen A, Stangel M, Stellmann JP, Stürner KH, Tackenberg B, Then Bergh F, Tumani H, Warnke C, Weber F, Wiendl H, Wildemann B, Zettl UK, Ziemann U, Zipp F, Arloth J, Weber P, Radivojkov-Blagojevic M, Scheinhardt MO, Dankowski T, Bettecken T, Lichtner P, Czamara D, Carrillo-Roa T, Binder EB, Berger K, Bertram L, Franke A, Gieger C, Herms S, Homuth G, Ising M, Jöckel KH, Kacprowski T, Kloiber S, Laudes M, Lieb W, Lill CM, Lucae S, Meitinger T, Moebus S, Müller-Nurasyid M, Nöthen MM, Petersmann A, Rawal R, Schminke U, Strauch K, Völzke H, Waldenberger M, Wellmann J, Porcu E, Mulas A, Pitzalis M, Sidore C, Zara I, Cucca F, Zoledziewska M, Ziegler A, Hemmer B, Müller-Myhsok B.  Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation

(JIF wird Mitte 2017 erstmals vergeben. Lt. Info des Journals wird dieser bei 33,610 in Anlehnung an das Journal 'Science' liegen.)  Sci Adv. 2(6):e1501678"

Barbe MT, Franklin J, Kraus D, Reker P, Dembek TA, Allert N, Wirths J, Voges J, Timmermann L, Visser-Vandewalle V.  Deep brain stimulation of the posterior subthalamic area and the thalamus in patients with essential tremor: study protocol for a randomized controlled pilot trial.  Trials. 17(1):476

Bauer A, Cassel W, Benes H, Kesper K, Rye D, Sica D, Winkelman JW, Bauer L, Grieger F, Joeres L, Moran K, Schollmayer E, Whitesides J, Carney HC, Walters AS, Oertel W, Trenkwalder C.  Rotigotine’s effect on PLM-associated blood pressure elevations in restless legs syndrome: an RCT.  Neurology 86(19): 1785-1793

Bauer S, Baier H, Baumgartner C, Bohlmann K, Fauser S, Graf W, Hillenbrand B, Hirsch M, Last C, Lerche H, Mayer T, Schulze-Bonhage A, Steinhoff BJ, Weber Y, Hartlep A, Rosenow F, Hamer HM.  Transcutaneous Vagus Nerve Stimulation (tVNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial (cMPsE02).  Brain Stimul. 9(3):356-63

Belger M, Haro JM, Reed C, Happich M, Kahle-Wrobleski K, Argimon JM, Bruno G, Dodel R, Jones RW, Vellas B, Wimo A.  How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study.  BMC Med Res Methodol. 16:83

Bliemel C, Sielski R, Doering B, Dodel R, Balzer-Geldsetzer M, Ruchholtz S, Buecking B.  Pre-fracture quality of life predicts 1-year survival in elderly patients with hip fracture-development of a new scoring system.  Osteoporos Int. 27(6):1979-87

Boeselt T, Nell C, Kehr K, Holland A, Dresel M, Greulich T, Tackenberg B, Kenn K, Boeder J, Klapdor B, Kirschbaum A, Vogelmeier C, Alter P, Koczulla AR. Whole-body vibration therapy in intensive care patients: A feasibility and safety study.   J Rehabil Med. 48(3):316-21

Brandt AU, Meinert-Bohn E, Rinnenthal JL, Zimmermann H, Mikolajczak J, Oberwahrenbrock T, Papazoglou S, Pfüller CF, Schinzel J, Tackenberg B, Paul F, Hahn K, Bellmann-Strobl J.  Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies.  PLoS One 11(10): e0164617

Chahine LM, Xie SX, Simuni T, Tran B, Postuma R, Amara A, Oertel WH, Iranzo A, Scordia C, Fullard M, Linder C, Purri R, Darin A, Rennert L, Videnovic A, Del Riva P, Weintraub D.  Longitudinal changes in cognition in early Parkinson’s disease patients with REM sleep behavior disorder.  Parkinsonism Rel Disord 27: 102-106

Dafsari HS, Reddy P, Herchenbach C, Wawro S, Petry-Schmelzer JN, Visser-Vandewalle V, Rizos A, Silverdale M, Ashkan K, Samuel M, Evans J, Huber CA, Fink GR, Antonini A, Chaudhuri KR, Martinez-Martin P, Timmermann L (on behalf of the IPMDS Non-Motor Symptoms Study Group).  Beneficial Effects of Bilateral Subthalamic Stimulation on Non-Motor Symptoms in Parkinson's Disease.  Brain Stimul. 9(1):78-85

Dams J, Balzer-Geldsetzer M, Siebert U, Deuschl G, Schuepbach WM, Krack P, Timmermann L, Schnitzler A, Reese JP, Dodel R (Early-Stim Investigators).  Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complications.  Mov Disord. 31(8):1183-91

Dembek TA, Barbe MT, Åström M, Hoevels M, Visser-Vandewalle V, Fink GR, Timmermann L.  Probabilistic mapping of deep brain stimulation effects in essential tremor.  Neuroimage Clin. 13:164-173

Eggert K, Antony G, Anvari K, Behrens S, Dapprich M, Ehret R, Lueer W, Nass, A, Pfister R, Planz-Kuhlendahl S, Reifschneider G, Simonow A, and Schwalbe M, Oertel WH.  A prospective, multicenter 2-year echocardiographic study on valvular heart disease in Parkinson's disease patients taking rotigotine and other non-ergot dopamine agonists.  J Alzheimers Dis Parkinsonism. 6:233

Fengler S, Kessler J, Timmermann L, Zapf A, Elben S, Wojtecki L, Tucha O, Kalbe E.  Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.  PLoS One. 11(7):e0159318

Fengler S, Roeske S, Heber I, Reetz K, Schulz JB, Riedel O, Wittchen HU, Storch A, Linse K, Baudrexel S, Hilker R, Mollenhauer B, Witt K, Schmidt N, Balzer-Geldsetzer M, Dams J, Dodel R, Gräber S, Pilotto A, Petrelli A, Fünkele S, Kassubek J, Kalbe E.  Variance of essential tremor patients' time reproduction deficits.  Mov Disord. 31(9):1428-9

Florin E, Pfeifer J, Visser-Vandewalle V, Schnitzler A, Timmermann L.  Parkinson subtype-specific Granger-causal coupling and coherence frequency in the subthalamic area.  Neuroscience. 332:170-80

Garcia-Borreguero D, Silber MH, Winkelman JW, Högl B, Bainbridge J, Buchfuhrer M, Hadjigeorgiou G, Inoue Y, Manconi M, Oertel W, Ondo W, Winkelmann J, Allen RP.  Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined  task force of the IRLSSG, EURLSSG and the RLS foundation.  Sleep Medicine 21: 1-11

Gorges M, Müller HP, Lulé D; LANDSCAPE Consortium (hierin: Dodel R), Pinkhardt EH, Ludolph AC, Kassubek J.  The association between alterations of eye movement control and cerebral intrinsic functional connectivity in Parkinson's disease.  Brain Imaging Behav. 10(1):79-91

Hagge M, Nunnemann S, Bauer S, Gollwitzer S, Oertel WH, Knake S, Rosenow F, Hamer HM.  Biceps electromyography in dialeptic and automotor seizures with and without secondary generalization.   Clin Neurophysiol. 127(2):1163-9

Hamel W, Köppen JA, Alesch F, Antonini A, Barcia JA, Bergman H, Chabardes S, Contarino MF, Cornu P, Demmel W, Deuschl G, Fasano A, Kühn AA, Limousin P, McIntyre CC, Mehdorn HM, Pilleri M, Pollak P, Rodríguez-Oroz MC, Rumià J, Samuel M, Timmermann L, Valldeoriola F, Vesper J, Visser-Vandewalle V, Volkmann J, Lozano AM.  Targeting of the subthalamic nucleus for deep brain stimulation: a survey among Parkinson's disease specialists.  World Neurosurg. S1878-8750(16)31156-1

Hansen N, Widman G, Witt JA, Wagner J, Becker AJ, Elger CE, Helmstaedter C.  Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis.  Epilepsy Behav. 65:18-24

Hennerici T, Pollmann R, Schmidt T, Seipelt M, Tackenberg B, Möbs C, Ghoreschi K, Hertl M, Eming R.  Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus.  PLoS One. 11(2):e0148919

Henshall DC, Hamer HM, Pasterkamp RJ, Goldstein DB, Kjems J, Prehn JH, Schorge S, Lamottke K, Rosenow F.  MicroRNAs in epilepsy: pathophysiology and clinical utility.  Lancet Neurol. 15(13):1368-1376

"Hermsen AM, Haag A, Duddek C, Balkenhol K, Bugiel H, Bauer S, Mylius V, Menzler K, Rosenow F.  Test-retest reliability of single and paired pulse transcranial magnetic stimulation parameters in healthy subjects.  J Neurol Sci. 362:209-16

Heßmann P, Seeberg G, Reese JP, Dams J, Baum E, Müller MJ, Dodel R, Balzer-Geldsetzer M.  Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings.   J Alzheimers Dis. 51(2):545-61

Huppertz HJ, Möller L, Südmeyer M, Hilker R, Hattingen E, Egger K, Amtage F, Respondek G, Stamelou M, Schnitzler A, Pinkhardt EH, Oertel WH, Knake S, Kassubek J, Höglinger GU.  Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification.  Mov. Disord. 31(10):1506-1517

Huys D, Bartsch C, Koester P, Lenartz D, Maarouf M, Daumann J, Mai JK, Klosterkötter J, Hunsche S, Visser-Vandewalle V, Woopen C, Timmermann L, Sturm V, Kuhn J.  Motor Improvement and Emotional Stabilization in Patients With Tourette Syndrome After Deep Brain Stimulation of the Ventral Anterior and Ventrolateral Motor Part of the Thalamus.  Biol Psychiatry. 79(5):392-401

Johannesen K, Marini C, Pfeffer S, Møller RS, Dorn T, Niturad C, Gardella E, Weber Y, Søndergård M, Hjalgrim H, Nikanorova M, Becker F, Larsen LH, Dahl HA, Maier O, Mei D, Biskup S, Klein KM, Reif PS, Rosenow F, Elias AF, Hudson C, Helbig KL, Schubert-Bast S, Scordo MR, Craiu D, Djémié T, Hoffman-Zacharska D, Caglayan H, Helbig I, Serratosa J, Striano P, De Jonghe P, Weckhuysen S, Suls A, Muru K, Talvik I, Talvik T, Muhle H, Borggraefe I, Rost I, Guerrini R, Lerche H, Lemke JR, Rubboli G, Maljevic S.  Phenotypic spectrum of GABRA1: From generalized epilepsies to severe epileptic encephalopathies.  Neurology 87(11):1140-51

Kalbe E, Rehberg SP, Heber I, Kronenbuerger M, Schulz JB, Storch A, Linse K, Schneider C, Gräber S, Liepelt-Scarfone I, Berg D, Dams J, Balzer-Geldsetzer M, Hilker R, Oberschmidt C, Witt K, Schmidt N, Mollenhauer B, Trenkwalder C, Spottke A, Roeske S, Wittchen HU, Riedel O, Dodel R.  Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.  J Neurol Neurosurg Psychiatry. 87(10):1099-105

Klein KM, Pendziwiat M, Cohen R, Appenzeller S, de Kovel CG, Rosenow F, Koeleman BP, Kuhlenbäumer G, Sheintuch L, Veksler R, Friedman A, Afawi Z, Helbig I.  Autosomal dominant epilepsy with auditory features: a new LGI1 family including a phenocopy with cortical dysplasia.  J Neurol. 263(1):11-6

Klietz M, Keber U, Carlsson T, Chiu WH, Höglinger GU, Weihe E, Schäfer MK, Depboylu C. (Klietz und Keber: geteilte Erstauthorenschaft). L-DOPA-induced dyskinesia is associated with a deficient numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons.  Neuroscience 331:120-33

Klotz L, Berthele A, Brück W, Chan A, Flachenecker P, Gold R, Haghikia A, Hellwig K, Hemmer B, Hohlfeld R, Korn T, Kümpfel T, Lang M, Limmroth V, Linker RA, Meier U, Meuth SG, Paul F, Salmen A, Stangel M, Tackenberg B, Tumani H, Warnke C, Weber MS, Ziemssen T, Zipp F, Wiendl H.  Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action.  Nervenarzt. 87(6):645-59

Kortland LM, Alfter A, Bähr O, Carl B, Dodel R, Freiman TM, Hubert K, Jahnke K, Knake S, von Podewils F, Reese JP, Runge U, Senft C, Steinmetz H, Rosenow F, Strzelczyk A.  Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany.  Epilepsia. 57(12):2056-2066

Kronimus Y, Albus A, Balzer-Geldsetzer M, Straub S, Semler E, Otto M, Klotsche J, Dodel R; LANDSCAPE Consortium., Mengel D.  Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.  PLoS One. 11(11):e0164953

Levin J, Maaß S, Schuberth M, Respondek, Paul F, Mannsmann U, Oertel WH, Lorenzl S, Krismer F, Seppi K, Poewe W, Wenning ; PROMESA study group (hierin: Eggert K), Giese A, Bötzel K, Höglinger G.  The PROMESA-protocol: progression rate of multiple systematrophy under EGCG supplementation as anti-aggregation-approach.  J Neural Transm 123(4): 439-445

Loehrer PA, Nettersheim FS, Jung F, Weber I, Huber C, Dembek TA, Pelzer EA, Fink GR, Tittgemeyer M, Timmermann L.  Ageing changes effective connectivity of motor networks during bimanual finger coordination.  Neuroimage. 143:325-342

Maier F, Lewis CJ, Horstkoetter N, Eggers C, Dembek TA, Visser-Vandewalle V, Kuhn J, Zurowski M, Moro E, Woopen C, Timmermann L.  Subjective perceived outcome of subthalamic deep brain stimulation in Parkinson's disease one year after surgery.  Parkinsonism Relat Disord. 24:41-7

Maier F, Williamson KL, Tahmasian M, Rochhausen L, Ellereit AL, Prigatano GP, Kracht L, Tang CC, Herz DM, Fink GR, Timmermann L, Eggers C.  Behavioural and neuroimaging correlates of impaired self-awareness of hypo- and hyperkinesia in Parkinson's disease.  Cortex. 82:35-47

Malter MP, Widman G, Galldiks N, Stoecker W, Helmstaedter C, Elger CE, Wagner,J.  Suspected new-onset autoimmune temporal lobe epilepsy with amygdala enlargement.  Epilepsia 57(9):1485-94

Melzer N, Ruck T, Fuhr P, Gold R, Hohlfeld R, Marx A, Melms A, Tackenberg B, Schalke B, Schneider-Gold C, Zimprich F, Meuth SG, Wiendl H.

Mengel D, Dams J, Ziemek J, Becker J, Balzer-Geldsetzer M, Hilker R, Baudrexel S, Kalbe E, Schmidt N, Witt K, Liepelt-Scarfone I, Gräber S, Petrelli A, Neuser P, Schulte C, Linse K, Storch A, Wittchen HU, Riedel O, Mollenhauer B, Ebentheuer J, Trenkwalder C, Klockgether T, Spottke A, Wüllner U, Schulz JB, Reetz K, Heber IA, Ramirez A, Dodel R.  Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.  Parkinsonism Relat Disord. 29:112-6

Mengel D, Thelen M, Balzer-Geldsetzer M, Söling C, Bach JP, Schaeffer E, Herold C, Becker T, Liepelt I, Becker J, Riedel-Heller S, Scherer M, Jessen F, Maier W, Dodel R, Ramirez A.  TREM2 rare variant p.R47H is not associated with Parkinson's disease.  Parkinsonism Relat Disord. 23:109-11

Meyer M, Kienzler-Norwood F, Bauer S, Rosenow F, Norwood BA.  Removing entorhinal cortex input to the dentate gyrus does not impede low frequency oscillations, an EEG-biomarker of hippocampal epileptogenesis.  Sci Rep. 6:256

Mylius V, Pee S, Pape H, Teepker M, Stamelou M, Eggert K, Lefaucheur JP, Oertel WH, Möller JC.  Experimental pain sensivity in multiple system atrophy and Parkinson's disease at an early stage.  Eur J Pain. 20(8):1223-8

Nalls MA, Keller MF, Hernandez DG, Chen L, Stone DJ, Singleton AB, Parkinson's Progression Marker Initiative PPMI investigators (hierin: Oertel WH).  Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI).  Mov Disord 31(1): 79-85

Nass RD, Kurth C, Kull A, Graf W, Kasper B, Hamer HM, Strzelczyk A, Elger CE, Steinhoff BJ, Surges R, Rosenow F.  Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany.  Epilepsy Behav. 56:54-8

Oertel WH, Deuschl G, Eggert K.  Das Kompetenznetzwerk Parkinson (KNP).  Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 59(4): 420-429

Oertel WH, Hallström Y, Saletu-Zyhlarz GM, Hopp M, Bosse B, Trenkwalder C (for the RELOXYN Study Group).  Sleep and quality of life under prolonged release oxycodone/naloxone for severe restless legs syndrome: an analysis of secondary efficacy variables of a double-blind, randomized, placebo-controlled study with an open-label extension.  CNS Drugs 30(8): 749-760

Pedrosa DJ, Nelles C, Maier F, Eggers C, Burghaus L, Fink GR, Wittmann M, Timmermann L.  Time reproduction deficits in essential tremor patients.  Mov Disord. 31(8):1234-40

Pedrosa DJ, Nelles C, Maier F, Eggers C, Burghaus L, Fink GR, Wittmann M, Timmermann L.  Time reproduction deficits in essential tremor patients.  Mov Disord. 31(8):1234-40

Quast I, Keller CW, Hiepe F, Tackenberg B, Lünemann JD.  Terminal complement activation is increased and associated with disease severity in CIDP.  Ann Clin Transl Neurol. 3(9):730-5

Reed C, Belger M, Vellas B, Andrews JS, Argimon JM, Brono G, Dodel R, Jones RW, Wimo A, Haro JM.  Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease.  Int. Psychogeriatr. 28(2):247-59

Richter M, Vidovic N, Honrath B, Mahavadi P, Dodel R, Dolga AM, Culmsee C.  Activation of SK2 channels preserves ER Ca2+ homeostasis and protects against ER stress-induced cell death.  Cell Death Differ. 23(5):814-27

Rohleder C, Wiedermann D, Neumaier B, Drzezga A, Timmermann L, Graf R, Leweke FM, Endepols H.  The Functional Networks of Prepulse Inhibition: Neuronal Connectivity Analysis Based on FDG-PET in Awake and Unrestrained Rats.  Front Behav Neurosci. 10:148

Rosenow F, Bast T, Czech T, Feucht M, Hans VH, Helmstaedter C, Huppertz HJ, Noachtar S, Oltmanns F, Polster T, Seeck M, Trinka E, Wagner K, Strzelczyk A.  Revised version of quality guidelines for presurgical epilepsy evaluation and surgical epilepsy therapy issued by the Austrian, German, and Swiss working group on presurgical epilepsy diagnosis and operative epilepsy treatment.  Epilepisia 57(8):1215-20

Rottscholl R, Haegele M, Jainsch B, Xu H, Respondek G, Höllerhage M, Rösler TW, Bony E, Le Ven J, Guérineau V, Schmitz-Afonso I, Champy P, Oertel WH, Yamada ES, Höglinger GU.  Chronic consumption of Annona muricata juice triggers and aggravates cerebral tau phosphorylation in wild-type and MAPT transgenic mice.  J Neurochem 139(4): 624-639

Sailer A, Scholz SW, Nalls MA, Schulte C, Federoff M, Price TR, Lees A, Ross OA, Dickson DW, Mok K, Mencacci NE, Schottlaender L, Chelban V, Ling H, O’Sullivan SS, Wood NW, Traynor BJ, Ferrucci L, Federoff HJ, Mhyre TR, Morris HR, Deuschl G, Quinn N, Widner H, Albanese A, Infante J, Bhatia KP, Poewe W, Oertel W, Hoeglinger GU, Wüllner U, Goldwurm S, Pellecchia MT, Ferreira J, Tolosa E, Bloem BR, Rascol O, Meissner WG, Hardy JA, Revesz T, Holton JL, Gasser T, Wenning GK, Singleton AB, Houlden H.  A genome-wide association study in multiple system atrophy.  Neurology 87(15): 1591-1598

Schrempf W, Katona I, Dogan I, Felbert VV, Wienecke M, Heller J, Maier A, Hermann A, Linse K, Brandt MD, Reichmann H, Schulz JB, Schiefer J, Oertel WH, Storch A, Weis J, Reetz K.  Reduced intraepidermal nerve fiber density in patients with REM sleep behavior disorder.  Parkinsonism Rel Disord 29: 10-16

Strzelczyk A, Bergmann A, Biermann V, Braune S, Dieterle L, Forth B, Kortland LM, Lang M, Peckmann T, Schöffski O, Sigel KO, Rosenow F.  Neurologist adherence to clinical practice guidelines and costs in patients with newly diagnosed and chronic epilepsy in Germany.  Epilepsy Behav. 64(Pt A):75-82

Strzelczyk A, Zschebek G, Bauer S, Baumgartner C, Grond M, Hermsen A, Kieslich M, Krämer G, Kurlemann G, May TW, Mayer T, Neubauer BA, Pfäfflin M, Plecko B, Ryvlin P, Schubert-Bast S, Stefan H, Trinka E, Knake S, Seifart C, Rosenow F.  Predictors of and attitudes toward counseling about SUDEP and other epilepsy risk factors among Austrian, German, and Swiss neurologists and neuropediatricians.  Epilepsia 57(4):612-20

Timmermann L, Jain R, Chen L, Brucke T, Seijo F, San Martin ES, Haegelen C, Verin M, Visser-Vandewalle V, Barbe MT, Gill S, Whone A, Porta M, Servello D, Alesch F.  134 VANTAGE Trial: Three-Year Outcomes of a Prospective, Multicenter Trial Evaluating Deep Brain Stimulation With a New Multiple-Source, Constant-Current Rechargeable System in Parkinson Disease.  Neurosurgery. 63 Suppl 1:155

Tison F, Keywood C, Wakefiel M, Durif F, Corvol JC, Eggert K, Lew M, Isaacxon S, Bezad E, Poli SM, Goetz CG, Trenkwalder C, Rascol O.  A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease.  Mov. Disord. 31(9):1373-80

Trenado C, Hartmann CJ, Elben S, Pauls KA, Friggemann L, Groiss SJ, Timmermann L, Vesper J, Schnitzler A, Wojtecki L.  Local field potential oscillations of the globus pallidus in cervical and tardive dystonia.  J Neurol Sci. 366:68-73

Trenkwalder C, Berg D, Rascol O, Eggert K, Ceballso-Baumann A, Corvol JC, Storch A, Zhang L, Azulay JP, Brousolle E, Defebvre L, Geny C, Gostkowski M, Stocchi F, Tranchant C, Derkinderen P, Durif F, Espay AJ, Feigin A, Houeto JL, Schwarz J, Di Paolo T, Feuerbach D, Hockey HU, Jaeger J, Jakab A, Johns D, Linazasoro G, Maruff P, Rozenberg I, Sovago J, Weiss M, Gomez-Mancilla B.  A Placebo-Controlled Trial of AQW051 in Patients with Moderate to Severe Levodopa-Induced Dyskinesia.  Mov Disord. 31(7): 1049-54

Vieira AS, de Matos AH, do Canto AM, Rocha CS, Carvalho BS, Pascoal VD, Norwood B, Bauer S, Rosenow F, Gilioli R, Cendes F, Lopes-Cendes I.

Wächter C, Eiden LE, Naumann N, Depboylu C, Weihe E. (Depboylu und Weihe: geteilte Letztauthorenschaft). Loss of cerebellar neurons in the progression of lentiviral disease: effects of CNS-permeant antiretroviral therapy.  J Neuroinflammation 13(1):272

Wobith M, Mayer C, Belke M, Haag A, Gerstner A, Teepker M, Strzelczyk A, Werner R, Hamer HM, Rosenow F, Menzler K, Knake S.  Predictors of New Cerebral Microbleeds in Patients with Antiplatelet Drug Therapy.  J Stroke Cerebrovasc Dis 25(7):1671-7

Ziemssen T, Gass A, Wuerfel J, Bayas A, Tackenberg B, Limmroth V, Linker R, Mäurer M, Haas J, Stangel M, Meergans M, Harlin O, Hartung HP.  Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.  BMC Neurol. 16:98

 

2015

 

Antonini A, Bauer L, Dohin E, Oertel WH, Rascol O, Reichmann H, Schmid M, Singh P, Tolosa E, Chaudhuri R,.  Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial.  Eur J Neurology. 22(10):1400-1407

Bach JP, Gold M, Mengel D, Hattesohl A, Lubbe D, Schmid S, Tackenberg B, Rieke J, Maddula S, Baumbach JI, Nell C, Boeselt T, Michelis J, Alferink J, Heneka M, Oertel W, Jessen F, Janciauskiene S, Vogelmeier C, Dodel R, Koczulla AR..  Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.  J Neurol Sci. 356(1-2):129-142

Belger M, Argimon JM, Dodel R, Haro JM, Wimo A, Reed C..  Comparing Resource Use In Alzheimer's Disease Across Three European Countries - 18-Month Results of The Geras Study.  Value Health. 18(7):A759-60

Belke M, Heverhagen JT, Keil B, Rosenow F, Oertel WH, Stiasny-Kolster K, Knake S, Menzler K.. DTI and VBM reveal white matter changes without associated gray matter changes in patients with idiopathic restless legs syndrome.  Brain Behav. 5(9):e00327

Best C, Tschan R, Stieber N, Beutel ME, Eckhardt-Henn A, Dieterich M..  STEADFAST: Psychotherapeutic Intervention Improves Postural Strategy of Somatoform Vertigo and Dizziness.  J Neurol Sci. 356(1-2):129-153

Bliemel C, Lechler P, Oberkircher L, Colcuc C, Balzer-Geldsetzer M, Dodel R, Ruchholtz S, Buecking B.    Effect of Preexisting Cognitive Impairment on In-Patient Treatment and Discharge Management among Elderly Patients with Hip Fractures.  Dement Geriatr Cogn Disord. 40(1-2):33-43

Buecking B, Bohl K, Eschbach D, Bliemel C, Aigner R, Balzer-Geldsetzer M, Dodel R, Ruchholtz S, Debus F.  Factors influencing the progress of mobilization in hip fracture patients during the early postsurgical period?-A prospective observational study.  Arch Gerontol Geriatr. 60(3):457-63

Chiu WH, Depboylu C, Hermanns G, Maurer L, Windolph A, Oertel WH, Ries V, Höglinger GU..  Long-term treatment with L-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson's disease.  J Neurol Sci. 356(1-2):129-141

Chiu WH, Depboylu C, Hermanns G, Maurer L, Windolph A, Oertel WH, Ries V, Höglinger GU. Long-term treatment with L-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson's disease. Neuropharmacology 95:367-76.

Dankowski T, Buck D, Andlauer TF, Antony G, Bayas A, Bechmann L, Berthele A, Bettecken T, Chan A, Franke A, Gold R, Graetz C, Haas J, Hecker M, Herms S, Infante-Duarte C, Jöckel KH, Kieseier BC, Knier B, Knop M, Kümpfel T, Lichtner P, Lieb W, Lill CM, Limmroth V, Linker RA, Loleit V, Meuth SG, Moebus S, Müller-Myhsok B, Nischwitz S, Nöthen MM, Paul F, Pütz M, Ruck T, Salmen A, Stangel M, Stellmann JP, Strauch K, Stürner KH, Tackenberg B, Then Bergh F, Tumani H, Waldenberger M, Weber F, Wiendl H, Wildemann B, Zettl UK, Ziemann U, Zipp F, Hemmer B, Ziegler A (German Competence Network for Multiple Sclerosis (KKNMS)).  Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array.  J Neurol Sci. 356(1-2):129-155

Depboylu C, Rösler TW, de Andrade A, Oertel WH, Höglinger GU..  Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.  J Neurol Sci. 356(1-2):129-155

Depboylu C, Rösler TW, de Andrade A, Oertel WH, Höglinger GU. Systemicallyadministered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease. J Neurochem 2015;133(4):590-7.

Dodel R, Belger M, Reed C, Wimo A, Jones RW, Happich M, Argimon JM, Bruno G, Vellas B, Haro JM..  Determinants of societal costs in Alzheimer's disease: GERAS study baseline results.  Alzheimers Dement. 11(8):933-45

Dong F, Eibach M, Bartsch JW, Dolga AM, Schlomann U, Conrad C, Schieber S, Schilling O, Biniossek ML, Culmsee C, Strik H, Koller G, Carl B, Nimsky C..  The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells.  J Neurol Sci. 356(1-2):129-159

Döring K, Best C, Birklein F, Krämer HH.. Zolmitriptan inhibits neurogenic inflammation and pain during electrical stimulation in human skin.  J Neurol Sci. 356(1-2):129-162

Eggers C, Günther M, Rothwell J, Timmermann L, Ruge D..  Theta burst stimulation over the supplementary motor area in Parkinson's disease.  J Neurol. 262(2):357-64

Gold M, Koczulla AR, Mengel D, Koepke J, Dodel R, Dontcheva G, Habib P, Bach JP..  Reduction of glutamate-induced excitotoxicity in murine primary neurons involving calpain inhibition.  J Neurol Sci. 356(1-2):129-148

Hardies K, May P, Djémié T, Tarta-Arsene O, Deconinck T, Craiu D; AR working group of the EuroEPINOMICS RES Consortium (hierin: Rosenow F und Klein KM), Helbig I, Suls A, Balling R, Weckhuysen S, De Jonghe P, Hirst J..  Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly.  J Neurol Sci. 356(1-2):129-147

Höglinger GU, Alvarez-Fischer D, Arrias-Carrion O, Djufri M, Windolph A, Keber U, Borta A, Ries V, Schwarting RK, Scheller D, Oertel WH..A new dopaminergic nigro-olfactory projection.  Acta Neuropathologica. 130:333-348

Holtbernd F, Ma Y, Peng S, Schwartz F, Timmermann L, Kracht L, Fink GR, Tang CC, Eidelberg D, Eggers C..  Dopaminergic correlates of metabolic network activity in Parkinson's disease.  Hum Brain Mapp. 36(9):3575-85

Kasteleijn-Nolst Trenité D, Brandt C, Mayer T, Rosenow F, Schmidt B, Steinhoff BJ, Gardin A, Imbert G, Johns D, Sagkriotis A, Kucher K..  Dose-dependent suppression of human photoparoxysmal response with the competitive AMPA/kainate receptor antagonist BGG492: Clear PK/PD relationship.  Epilepsia. 56(6):924-32

Kay L, Reif PS, Belke M, Bauer S, Fründ D, Knake S, Rosenow F, Strzelczyk A.. Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic-clonic seizures.  J Neurol Sci. 356(1-2):129-139

Keber U, Klietz M, Carlsson T, Oertel WH, Weihe E, Schäfer MK, Höglinger GU, Depboylu C. Striatal tyrosine hydroxylase-positive neurons are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Neuroscience 298:302-17.

Keber U, Klietz M, Carlsson T, Oertel WH, Weihe E, Schäfer MK, Höglinger GU, Depboylu C..  Striatal tyrosine hydroxylase-positive neurons are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.  J Neurol Sci. 356(1-2):129-154

Kohl S, Gruendler TO, Huys D, Sildatke E, Dembek TA, Hellmich M, Vorderwulbecke M, Timmermann L, Ahmari SE, Klosterkoetter J, Jessen F, Sturm V, Visser-Vandewalle V, Kuhn J..  Effects of deep brain stimulation on prepulse inhibition in obsessive-compulsive disorder.  Transl Psychiatry. 5:e675

Kolodziej M, Goetz C, Di Fazio P, Montalbano R, Ocker M, Strik H, Quint K.. Roscovitine has anti-proliferative and pro-apoptotic effects on glioblastoma cell lines: A pilot study.  J Neurol Sci. 356(1-2):129-150

Lal D, Pernhorst K, Klein KM, Reif P, Tozzi R, Toliat MR, Winterer G, Neubauer B, Nürnberg P, Rosenow F, Becker F, Lerche H, Kunz WS, Kurki MI, Hoffmann P, Becker AJ, Perucca E, Zara F, Sander T, Weber YG.. Extending the phenotypic spectrum of RBFOX1 deletions: Sporadic focal epilepsy.  Epilepsia. 56(9):e129-33

Lal D, Ruppert AK, Trucks H, Schulz H, de Kovel CG, Kasteleijn-Nolst Trenité D, Sonsma AC, Koeleman BP, Lindhout D, Weber YG, Lerche H, Kapser C, Schankin CJ, Kunz WS, Surges R, Elger CE, Gaus V, Schmitz B, Helbig I, Muhle H, Stephani U, Klein KM, Rosenow F, Neubauer BA, Reinthaler EM, Zimprich F, Feucht M, Møller RS, Hjalgrim H, De Jonghe P, Suls A, Lieb W, Franke A, Strauch K, Gieger C, Schurmann C, Schminke U, Nürnberg P; EPICURE Consortium (hierin: Reif PS, Oertel WH), Sander T..  Burden analysis of rare microdeletions suggests a strong impact of neurodevelopmental genes in genetic generalised epilepsies.  PLoS Genet. 11(5):e1005226

Lal D, Steinbrücker S, Schubert J, Sander T, Becker F, Weber Y, Lerche H, Thiele H, Krause R, Lehesjoki AE, Nürnberg P, Palotie A, Neubauer BA, Muhle H, Stephani U, Helbig I, Becker AJ, Schoch S, Hansen J, Dorn T, Hohl C, Lüscher N; Epicure consortium; EuroEPINOMICS-CoGIE consortium (hierin: Klein KM, Reif PS, Oertel WH, Rosenow F), von Spiczak S, Lemke JR.  Investigation of GRIN2A in common epilepsy phenotypes.  J Neurol Sci. 356(1-2):129-140

Larsen J, Carvill GL, Gardella E, Kluger G, Schmiedel G, Barisic N, Depienne C, Brilstra E, Mang Y, Nielsen JE, Kirkpatrick M, Goudie D, Goldman R, Jähn JA, Jepsen B, Gill D, Döcker M, Biskup S, McMahon JM, Koeleman B, Harris M, Braun K, de Kovel CG, Marini C, Specchio N, Djémié T, Weckhuysen S, Tommerup N, Troncoso M, Troncoso L, Bevot A, Wolff M, Hjalgrim H, Guerrini R, Scheffer IE, Mefford HC, Møller RS; EuroEPINOMICS RES Consortium CRP (hierin: Rosenow F und Klein KM)..  The phenotypic spectrum of SCN8A encephalopathy.  J Neurol Sci. 356(1-2):129-160

Lautenschläger G, Habig K, Best C, Kaps M, Elam M, Birklein F, Krämer HH.. The impact of baroreflex function on endogenous pain control - a microneurography study.  J Neurol Sci. 356(1-2):129-158

Lerche S, Liepelt-Scarfone I, Alves G, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Burn D, Dodel R, Grosset D, Heinzel S, Hu M, Kasten M, Krüger R, Maetzler W, Moccia M, Mollenhauer B, Oertel WH, Roeben B, Sünkel U, Walter U, Wirdefeldt K, Berg D.  Methods in neuroepidemiology: Characterization of European longitudinal cohort studies in Parkinson's disease - report of the JPND working group BioLoC-PD.  J Neurol Sci. 356(1-2):129-143

Lewis CJ, Maier F, Horstkötter N, Eggers C, Visser-Vandewalle V, Moro E, Zurowski M, Kuhn J, Woopen C, Timmermann L..  The impact of subthalamic deep brain stimulation on caregivers of Parkinson's disease patients: an exploratory study.  J Neurol. 262(2):337-45

Lewis CJ, Maier F, Horstkötter N, Zywczok A, Witt K, Eggers C, Meyer TD, Dembek TA, Maarouf M, Moro E, Zurowski M, Woopen C, Kuhn J, Timmermann L..  Subjectively perceived personality and mood changes associated with subthalamic stimulation in patients with Parkinson's disease.  Psychol Med. 45(1):73-85

Maier F, Ellereit AL, Eggers C, Lewis CJ, Pelzer EA, Kalbe E, Ernstmann N, Prigatano GP, Fink GR, Timmermann L..  Development and psychometric evaluation of a scale to measure impaired self-awareness of hyper- and hypokinetic movements in Parkinson's disease.  J Int Neuropsychol Soc. 21(3):221-30

Markser A, Maier F, Lewis CJ, Dembek TA, Pedrosa D, Eggers C, Timmermann L, Kalbe E, Fink GR, Burghaus L..  Deep brain stimulation and cognitive decline in Parkinson's disease: The predictive value of electroencephalography.  J Neurol. 262(10):2275-84

Martinez-Martin P, Reddy P, Katzenschlager R, Antonini A, Todorova A, Odin P, Henriksen T, Martin A, Calandrella D, Rizos A, Bryndum N, Glad A, Dafsari HS, Timmermann L, Ebersbach G, Kramberger MG, Samuel M, Wenzel K, Tomantschger V, Storch A, Reichmann H, Pirtosek Z, Trost M, Svenningsson P, Palhagen S, Volkmann J, Chaudhuri KR..  EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease.  Mov Disord. 30(4):510-6

Matschke LA, Bertoune M, Roper J, Snutch TP, Oertel WH, Rinne S, Decher N..  A concerted action of L- and T-type Ca²˖ channels regulates locus coeruleus pacemaking.  Mol Cell Neurosci. 68:293-302

Michely J, Volz LJ, Barbe MT, Hoffstaedter F, Viswanathan S, Timmermann L, Eickhoff SB, Fink GR, Grefkes C.. Dopaminergic modulation of motor network dynamics in Parkinson's disease.  Brain. 138(Pt 3):664-78

Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott CA, Tozer DJ, MacManus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT; CONFIRM study investigators (hierin: Tackenberg B).  Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.  Neurology. 84(11):1145-52

Nalls MA, McLean CY, Rick J, Eberly S, Hutten SJ, Gwinn K, Sutherland M, Martinez M, Heu-tink P, Williams NM, Hardy J, Gasser T, Brice A, Price TR, Nicolas A, Keller MF, Molony C, Gibbs JR, Chen-Plotkin A, Suh E, Letson C, Fiandaca MS, Mapstone M, Federoff HJ, Noyce AJ, Morris H, Van Deerlin VM, Weintraub D, Zabetian C, Hernandez DG, Lesage S, Mullins M, Conley ED, Northover CA, Frasier M, Marek K, Day-Williams AG, Stone DJ, Iannidis JP, Singleton AB, Parkinson's Disease Biomarkers Program and Parkinson's Progression Marker Initiative investigators (hierin: Oertel WH)..  Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.  Lancet Neurol. 14(10):1002-1009

Noda AH, Hermsen A, Berkenfeld R, Dennig D, Endrass G, Kaltofen J, Safavi A, Wiehler S, Carl G, Meier U, Elger CE, Menzler K, Knake S, Rosenow F, Strzelczyk A..  Evaluation of costs of epilepsy using an electronic practice management software in Germany.  Seizure. 26:49-55

Noelker C, Lu L, Höllerhage M, Vulinovic F, Sturn A, Roscher R, Höglinger GU, Hirsch EC, Oertel WH, Alvarez-Fischer D, Andreas H.  Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease.  J Neurol Sci. 356(1-2):129-136

Paulus FM, Krach S, Blanke M, Roth C, Belke M, Sommer J, Müller-Pinzler L, Menzler K, Jansen A, Rosenow F, Bremmer F, Einhäuser W, Knake S.. Fronto-insula network activity explains emotional dysfunctions in juvenile myoclonic epilepsy: combined evidence from pupillometry and fMRI.  Cortex. 65:219-31

Petrelli A, Kaesberg S, Barbe MT, Timmermann L, Rosen JB, Fink GR, Kessler J, Kalbe E..  Cognitive training in Parkinson's disease reduces cognitive decline in the long term.  Eur J Neurol. 22(4):640-7

Poewe W, Seppi K, Fitzer-Attas CJ, Wenning GK, Gilman S, Low PA, Giladi N, Barone P, Sampaio C, Eyal E, Rascol O; Rasagiline-for-MSA investigators (hierin Oertel WH).. Rasagiline-for-MSA investigators (…Oertel WH…). Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial.  J Neurol Sci. 356(1-2):129-146

Postuma RB, Iranzo A, Hogl B, Arnulf I, Ferini-Strambi L, Manni R, Miyamoto T, Oertel WH, Dauvilliers Y, Ju Y, Puligheddu M, Sonka K, Pelletier A, Santamaria J, Frauscher B, Leu-Semenescu S, Zucconi M, Terzaghi M, Miyamoto M, Unger MM, Carlander B, Fantini ML, Montplaisir JY..  Risk Factors for Neurodegeneration in Idiopathic REM sleep Behavior Disorder: A Multicenter Study.  J Neurol Sci. 356(1-2):129-149

Quast I, Cueni F, Nimmerjahn F, Tackenberg B, Lünemann JD..  Deregulated Fcγ receptor expression in patients with CIDP.  Neurol Neuroimmunol Neuroinflamm. 2(5):e148

Quast I, Keller CW, Maurer MA, Giddens JP, Tackenberg B, Wang LX, Münz C, Nimmerjahn F, Dalakas MC, Lünemann JD..  Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.  J Neurol Sci. 356(1-2):129-151

Reed C, Belger M, Vellas B, Andrews JS, Argimon JM, Brono G, Dodel R, Jones RW, Wimo A, Haro JM.  Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease. J Neurol Sci. 356(1-2):129-138

Reese JP, Hamer H, OertelWH, Strzelczyk A, Mueller UO, Heilmaier C, Kostev K..  Association of time-to-levodopa with initial Parkinsonian medication: a retrospective cohort study.  Int J Clin Pharm Ther. 53(2):107-114

Reetz K, Dogan I, Costa AS, Dafotakis M, Fedosov K, Giunti P, Parkinson MH, Sweeney MG, Mariotti C, Panzeri M, Nanetti L, Arpa J, Sanz-Gallego I, Durr A, Charles P, Boesch S, Nachbauer W, Klopstock T, Karin I, Depondt C, vom Hagen JM, Schöls L, Giordano IA, Klockgether T, Bürk K, Pandolfo M, Schulz JB..  Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data.  Lancet Neurol. 14(2):174-82

Richter M, Nickel C, Apel L, Kaas A, Dodel R, Culmsee C, Dolga AM..  SK channel activation modulates mitochondrial respiration and attenuates neuronal HT-22 cell damage induced by H2O2.  J Neurol Sci. 356(1-2):129-152

Riechmann J, Strzelczyk A, Reese JP, Boor R, Stephani U, Langner C, Neubauer BA, Oberman B, Philippi H, Rochel M, Seeger J, Seipelt P, Oertel WH, Dodel R, Rosenow F, Hamer HM (EpiPaed Study Group)..  Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany.  Epilepsia. 56(9):1388-97

Ruckmann J, Bodden M, Jansen A, Kircher T, Dodel R, Rief W. How pain empathy depends on ingroup/outgroup decisions: A functional magnet resonance imaging study.  J Neurol Sci. 356(1-2):129-137

Sauer T, Silling G, Groth C, Rosenow F, Krug U, Görlich D, Evers G, Albring J, Besoke R, Mesters RM, Müller-Tidow C, Kessler T, Büchner T, Berdel WE, Stelljes M..  Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT.  J Neurol Sci. 356(1-2):129-161

Schöls L, Reimold M, Seidel K, Globas C, Brockmann K, Karsten Hauser T, Auburger G, Bürk K, den Dunnen W, Reischl G, Korf HW, Brunt ER, Rüb U.  No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.  J Neurol Sci. 356(1-2):129-14

Schuff N, Wu IW, Buckley S, Foster ED, Coffey CS, Gitelman DR, Mendick S, Seibyl J, Simuni T, Zhang Y, Jankovic J, Hunter C, Tanner CM, Rees L, Factor S, Berg D, Wurster I, Gauss K, Sprenger F, Seppi K, Poewe W, Mollenhauer B, Knake S, Mari Z, McCoy A, Ranola M, Marek K..  Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.  Mov Disord. 30(14):1885-92

Schüller T, Gruendler TO, Jocham G, Klein TA, Timmermann L, Visser-Vandewalle V, Kuhn J, Ullsperger M..  Rapid feedback processing in human nucleus accumbens and motor thalamus.  Neuropsychologia. 70:246-54

Simuni T, Caspell-Garcia C, Coffey C, Chahine LM, Lasch S, Oertel WH, Mayer G, Högl B, Postuma R, Videnovic A, Amara AW, Marek K.. PPMI Sleep Working group on behalf of the PPMI Investigators. Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.  J Neurol Sci. 356(1-2):129-14

Simuni T, Caspell-Garcia C, Coffey C, Chahine LM, Lasch S, Oertel WH, Mayer G, Högl B, Postuma R, Videnovic A, Amara AW, Marek K; PPMI Sleep Working group on behalf of the PPMI Investigators..  Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.  Mov Disord. 30(10): 1371-81

Stamelou M, Diehl-Schmid J, Hapfelmeier A, Kontaxopoulou D, Stefanis L, Oertel WH, Bhatia KP, Papageorgiou SG, Höglinger GU.. The frontal assessment battery is not useful to discrimi-nate progressive supranuclear palsy from frontotemporal dementias.  J Neurol Sci. 356(1-2):129-157

Stamelou M, Pilatus U, Reuss A, Respondek G, Knake S, Oertel WH, Höglinger GU.. Brain energy metabolism in early MSA-P: a phosphorus and proton magnetic resonance spectroscopy study.  Parkinsonism Rel Disord. 21(5):533-535

Syrbe S, Hedrich UB, Riesch E, Djémié T, Müller S, Møller RS, Maher B, Hernandez-Hernandez L, Synofzik M, Caglayan HS, Arslan M, Serratosa JM, Nothnagel M, May P, Krause R, Löffler H, Detert K, Dorn T, Vogt H, Krämer G, Schöls L, Mullis PE, Linnankivi T, Lehesjoki AE, Sterbova K, Craiu DC, Hoffman-Zacharska D, Korff CM, Weber YG, Steinlin M, Gallati S, Bertsche A, Bernhard MK, Merkenschlager A, Kiess W; EuroEPINOMICS RES (hierin: Klein KM, Rosenow F), Gonzalez M, Züchner S, Palotie A, Suls A, De Jonghe P, Helbig I, Biskup S, Wolff M, Maljevic S, Schüle R, Sisodiya SM, Weckhuysen S, Lerche H, Lemke JR..  De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.  Nat Genet. 47(4):393-9

Tahmasian M, Rochhausen L, Maier F, Williamson KL, Drzezga A, Timmermann L, Van Eimeren T, Eggers C..  Impulsivity is Associated with Increased Metabolism in the Fronto-Insular Network in Parkinson's Disease.  Front Behav Neurosci. 9:317

Timmermann L, Asgharnejad M, Boroojerdi B, Dohin E, Woltering F, Elmer LW..  Impact of 6-month earlier versus postponed initiation of rotigotine on long-term outcome: post hoc analysis of patients with early Parkinson's disease with mild symptom severity.  Expert Opin Pharmacother. 16(10):1423-33

Timmermann L, Jain R, Chen L, Maarouf M, Barbe MT, Allert N, Brücke T, Kaiser I, Beirer S, Sejio F, Suarez E, Lozano B, Haegelen C, Vérin M, Porta M, Servello D, Gill S, Whone A, Van Dyck N, Alesch F..  Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.  Lancet Neurol. 14(7):693-701

Wiendl H, Elger C, Förstl H, Hartung HP, Oertel WH, Reichmann H, Schwab S.  Gaps between aims and achievements in therapeutic modification of neuronal damage ("neuroprotection").  Neurotherapeutics. 12(2):449-454

Woitalla D, Kassubek J, Timmermann L, Lauterbach T, Berkels R, Grieger F, Müller T..  Reduction of gastrointestinal symptoms in Parkinson's disease after a switch from oral therapy to rotigotine transdermal patch: a non-interventional prospective multicenter trial.  Parkinsonism Relat Disord. 21(3):199-204

Ziemssen T, Albrecht H, Haas J, Klotz L, Lang M, Lassek C, Schmidt S, Tackenberg B, Cornelissen C..  36 Months Pangaea: A 5-Year Non-Interventional Study of Safety, Efficacy and Pharmacoeconomic Data for Fingolimod Patients In Daily Clinical Practice.  Value Health. 18(7):A749

 

2014

 

Depboylu C, Klietz M, Maurer L, Oertel WH, Kobayashi K, Weihe E, Höglinger GU, Schäfer MK. Transcriptional and structural plasticity of tyrosine hydroxylase expressing neurons in both striatum and nucleus accumbens following dopaminergic denervation. J Chem Neuroanat 2014;61-62:169-75.

Rösler TW, Matusch A, Librizzi D, Arias-Carrión O, Freundlieb N, Hoeffken H, Oertel WH, Depboylu C, Höglinger GU. Diesterified derivatives of 5-iodo-2'-deoxyuridine as cerebral tumor tracers. PLoS One 2014;9(7):e102397.

Ridder K, Keller S, Dams M, Rupp AK, Schlaudraff J, Del Turco D, Starmann J, Macas J, Karpova D, Devraj K, Depboylu C, Landfried B, Arnold B, Plate KH,Höglinger G, Sültmann H, Altevogt P, Momma S. Extracellular vesicle-mediated transfer of genetic information between the hematopoietic system and the brain in response to inflammation. PLoS Biol 2014;12(6):e1001874.

Lahut S, Vadasz D, Depboylu C, Ries V, Krenzer M, Stiasny-Kolster K, Basak AN, Oertel WH, Auburger G. The PD-associated alpha-synuclein promoter Rep1 allele 2 shows diminished frequency in restless legs syndrome. Neurogenetics 2014;15(3):189-92.

Depboylu C. Non-serine-phosphorylated tyrosine hydroxylase expressing neurons are present in mouse striatum, accumbens and cortex that increase in number following dopaminergic denervation. J Chem Neuroanat 2014;56:35-44.

Oertel WH, Depboylu C, Krenzer M, Vadasz D, Ries V, Sixel-Döring F, Mayer G. [REM sleep behavior disorder as a prodromal stage of α-synucleinopathies: symptoms, epidemiology, pathophysiology, diagnosis and therapy]. Nervenarzt 2014;85(1):19-25.

Chiu WH, Carlsson T, Depboylu C, Höglinger GU, Oertel WH, Ries V. Selegiline normalizes, while l-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson's disease. Neuropharmacology 2014;79:212-21.

 

2013

 

Chiu WH, Carlsson T, Depboylu C, Höglinger GU, Oertel WH, Ries V.  Selegiline normalizes, while l-DOPA sustains the increased number ofdopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson's disease. Neuropharmacology 2013;79C:212-21.

Noelker C, Morel L, Lescot T, Osterloh A, Alvarez-Fischer D, Breloer M, Henze C, Depboylu C, Skrzydelski D, Michel PP, Dodel RC, Lu L, Hirsch EC,Hunot S, Hartmann A. Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Sci Rep 2013;3:1393.

Depboylu C, Maurer L, Matusch A, Hermanns G, Windolph A, Béhé M, Oertel WH, Höglinger GU. Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [123I]FP-CIT SPECT and histochemistry. Neuroimage 2013;79:191-200.

Li G, Nowak M, Bauer S, Schlegel K, Stei S, Allenhöfer L, Waschbisch A, Tackenberg B, Höllerhage M, Höglinger GU, Wegner S, Wang X, Oertel WH, Rosenow F, Hamer HM. Levetiracetam but not valproate inhibits function of CD8+ T lymphocytes. Seizure 2013;22(6):462-6.

Respondek G, Roeber S, Kretzschmar H, Troakes C, Al-Sarraj S, Gelpi E, Gaig C, Chiu WZ, van Swieten JC, Oertel WH, Höglinger GU. Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy. Mov Disord 2013;28(4):504-9.